# Thalidomide Versus Argon Plasma Coagulation in Gastric Antral Vascular Ectasia(GAVE)-Related Anaemia in Cirrhosis (TAG Trial)

> **NCT06772480** · NA · NOT_YET_RECRUITING · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 100 (estimated)

## Conditions studied

- Liver Cirrhosis
- Gastric Antral Vascular Ectasia

## Interventions

- **DRUG:** Thalidomide
- **PROCEDURE:** Argon Plasma Coagulation

## Key facts

- **NCT ID:** NCT06772480
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-05
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06772480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06772480, "Thalidomide Versus Argon Plasma Coagulation in Gastric Antral Vascular Ectasia(GAVE)-Related Anaemia in Cirrhosis (TAG Trial)". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06772480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*